Follow the Scancell Holdings plc stock price and the full insider trade history of the company, a listed issuer based in United Kingdom. Shares are listed on the UK market, under the oversight of RNS (LSE). The latest transaction was reported on 4 August 2025 (Purchase). Among the most active insiders: Vulpes Testudo Fund. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Scancell Holdings plc es una empresa biofarmacéutica con sede en el Reino Unido enfocada en el desarrollo de tratamientos inmunoterapéuticos para el cáncer. Se concentra en enfoques innovadores para estimular los sistemas inmunológicos de los pacientes.